• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 24-38 of 132 results

9 Refund Request: Petitioners Request for Refund of IPR Fees

Document IPR2017-00645, No. 9 Refund Request - Petitioners Request for Refund of IPR Fees (P.T.A.B. Apr. 20, 2017)

cite Cite Document
Analyze

4 Mandatory Notice: Patent Owners Mandatory Notices

Document IPR2017-00645, No. 4 Mandatory Notice - Patent Owners Mandatory Notices (P.T.A.B. Feb. 15, 2017)

cite Cite Document
Analyze

5 Power of Attorney: Patent Owner Power of Attorney

Document IPR2017-00645, No. 5 Power of Attorney - Patent Owner Power of Attorney (P.T.A.B. Feb. 15, 2017)

cite Cite Document
Analyze

1 Power of Attorney: Petitioners Power of Attorney

Document IPR2017-00645, No. 1 Power of Attorney - Petitioners Power of Attorney (P.T.A.B. Jan. 19, 2017)

cite Cite Document
Analyze

LEVOTHYROXINE SODIUM

Docket 202231, Orange Book (June 24, 2011)

cite Cite Docket
Analyze

1007 Exhibit: Mylan EX 1007 APP Levothyroxine Sodium

Document IPR2017-00645, No. 1007-7 Exhibit - Mylan EX 1007 APP Levothyroxine Sodium (P.T.A.B. Jan. 19, 2017)

cite Cite Document
Analyze

1044 Exhibit: Mylan EX 1044 Amendment and Response dated July 13, 2015

Document IPR2017-00645, No. 1044-33 Exhibit - Mylan EX 1044 Amendment and Response dated July 13, 2015 (P.T.A.B. Jan. 19, 2017)

cite Cite Document
Analyze

1026 Exhibit: Mylan EX 1026 Amendment and Response dated December 23, 2014

Document IPR2017-00645, No. 1026-22 Exhibit - Mylan EX 1026 Amendment and Response dated December 23, 2014 (P.T.A.B. Jan. 19, 2017)

cite Cite Document
Analyze

1034 Exhibit: Mylan EX 1034 Prescribing Info Levothyroxine Sodium

Document IPR2017-00645, No. 1034-25 Exhibit - Mylan EX 1034 Prescribing Info Levothyroxine Sodium (P.T.A.B. Jan. 19, 2017)

cite Cite Document
Analyze

1057 Exhibit: Mylan EX 1057 Brown TL, Lemay HE Jr, Bursten BE, Chemistry,

Document IPR2017-00645, No. 1057-45 Exhibit - Mylan EX 1057 Brown TL, Lemay HE Jr, Bursten BE, Chemistry, (P.T.A.B. Jan. 19, 2017)

cite Cite Document
Analyze

1019 Exhibit: Mylan EX 1019 Glass et al, Excerpt

Document IPR2017-00645, No. 1019-19 Exhibit - Mylan EX 1019 Glass et al, Excerpt (P.T.A.B. Jan. 19, 2017)

cite Cite Document
Analyze

1052 Exhibit: Mylan EX 1052 US Patent No 6,284,277

Document IPR2017-00645, No. 1052-41 Exhibit - Mylan EX 1052 US Patent No 6,284,277 (P.T.A.B. Jan. 19, 2017)

cite Cite Document
Analyze

1042 Exhibit: Mylan EX 1042 Michael J Akers, Sterile Drug Products

Document IPR2017-00645, No. 1042-31 Exhibit - Mylan EX 1042 Michael J Akers, Sterile Drug Products (P.T.A.B. Jan. 19, 2017)

cite Cite Document
Analyze

1009 Exhibit: Mylan EX 1009 Collier et al, Excerpt

Document IPR2017-00645, No. 1009-9 Exhibit - Mylan EX 1009 Collier et al, Excerpt (P.T.A.B. Jan. 19, 2017)

cite Cite Document
Analyze

1048 Exhibit: Mylan EX 1048 Kim et al, Excerpt

Document IPR2017-00645, No. 1048-37 Exhibit - Mylan EX 1048 Kim et al, Excerpt (P.T.A.B. Jan. 19, 2017)

cite Cite Document
Analyze
<< 1 2 3 4 5 6 ... 8 9 10 >>